FDA HAS NO “FULLY AUTHORIZED” VACCINES

BUT DC OFFICIALS STILL REQUIRE THEM FOR STUDENTS 

D.C. Law 24-85. Coronavirus Immunization of School Students and Early Childhood Workers Regulation Amendment Act of 2021 requires “that eligible students in the District of Columbia receive a vaccination that is fully approved in the United States to prevent against COVID-19”. 

It clarifies with this clause: 

“(3) “COVID-19 vaccine” means a vaccine against COVID-19 for which the U.S. Food and Drug Administration has granted full approval as opposed to emergency use authorization.”

However, the FDA only has Emergency Use Vaccines, and none of them have become fully-approved yet.

Pfizer-BioNTech: Full Emergency Use since August 2022.

Comirnaty: Emergency Use, according to Comirnaty’s website.

Novavax: Emergency Use since July 2022.

Moderna/SpikeVax: Emergency Use since January 2022.

This important detail has been disregarded by the Mayor, who promotes compliance for ‘required vaccinations’ and the Council who created the legislation.